Treatment

Painful bladder syndrome / Interstitial cystitis

Treatments for painful bladder syndrome or interstitial cystitis

In the initial stages, or as part of a combined approach, the following may be indicated:

• Pharmacological treatments aimed at reducing inflammation and pain.
• Medication to reduce urinary urgency and frequency.
• Behavioral measures and lifestyle modifications, including dietary recommendations and control of bladder irritants.

These treatments may be helpful in some patients, although in many cases they do not provide sustained long-term relief.

Intravesical treatments

Intravesical therapies involve the direct administration of substances into the bladder with the aim of:

• Protect the bladder mucosa.
• Reduce chronic inflammation.
• Improve the function of the urothelial barrier.

Its effectiveness may vary between patients, and sometimes the results are temporary.

Pelvic floor physical therapy

In selected patients, specialized pelvic floor physical therapy may be part of the treatment, especially when there is:

• Muscle hypertonia.
• Pain associated with muscle spasms or pelvic muscle dysfunction.

This approach aims to improve muscle control and reduce pain associated with the musculoskeletal system.

Regenerative treatments: Platelet-Rich Plasma (PRP)

When conventional treatments do not offer sufficient improvement, there are regenerative alternatives that seek to address the root cause of the problem.

Platelet-rich plasma (PRP) is an autologous treatment obtained from the patient's own blood, rich in growth factors and molecules with anti-inflammatory and regenerative effects.

In the context of chronic bladder pain and interstitial cystitis, PRP may contribute to:

• Reduce chronic inflammation of the bladder.
• Promote urothelium regeneration.
• Improve the protective barrier of the bladder.
• Reduce pain, urinary urgency, and urinary frequency.

As this is an autologous procedure, the risk of rejection or adverse reactions is minimal.